The crude CH 2 Cl 2 /MeOH extract of the air-dried epigeal parts of D. graveolens showed significant bioactivities (vide infra). This extract was then subjected to flash column chromatography over a Silica gel, eluted with hexane, In bioassay-guided searches for novel bioactive natural products from higher plants of the Egyptian flora, two new eudesmane sesquiterpene derivatives, 3a a-hydroxyilicic acid methyl ester (1) and 2a a-hydroxy-4-epi-ilicic acid (2), together with 11 known sesquiterpenes were isolated from bioactive fractions of the active epigeal parts extracts of Dittrichia graveolens (L.) GREUTER (Asteraceae) growing in the coastal regions of northwestern Egypt. 
The genus Inula L. (Asteraceae, tribe Inuleae, subtribe Inulinae) comprises ca. 100 species and are distributed throughout Europe and Asia, although there are also several African species.
1) Many species of Inula are traditionally used as folk medicine in the treatment of ischemic heart disease, 2) angina pectoris, 3) hypoglycemia, 4) liver disorders, 5, 6) gastroduodenal diseases and ulcers, 7) bronchia, rheumatic complaints, migraine and skin infection, 8) as a lung tonic and analgesic, 8) and as an antiproliferative. 6, 9) The characteristic constituents of the genus Inula are sesquiterpene lactones [10] [11] [12] [13] and essential oil groups. 14) Some phenolic acids and flavonoids were detected as additional constituents of this genus. 15, 16) Sesquiterpene lactones (STLs) occur in many plant families but are most widely distributed within the Asteraceae (Compositae, sunflower family) in which the majority of almost 4000 naturally occurring STLs have been found. 1) These lactones have been reported to possess a diversity of conspicuous biological activities, such as cytotoxic, antitumorigenic, and highly bactericidal and fungicidal properties. 13, [17] [18] [19] [20] [21] [22] [23] Many of these compounds or plants containing them are a cause of allergic contact dermatitis in humans. 18) On the other hand, some of these lactones have been reported to possess a wide spectrum of pharmacological activities, such as hypotensive, hyperglycemic (high doses) and hypoglycemic (lower doses), 24) anthelminthic, 21) diuretic, 25) antiinflammatory, and antipyretic. [26] [27] [28] They have also been used therapeutically as expectorants, cholagouge, and to lower blood pressure. 18) Dittrichia graveolens (L.) GREUTER (Syn. Inula graveolens) is an annual herbaceous plant that grows about 80 cm high and is widespread in the Mediterranean area. It grows along roadsides, on waste ground, in humid and degraded soils, and near subsalt lands. Its presence in the coastal regions of northwestern Egypt has recently been recorded. 29) This species is well known for its essential oil content. 30) The essential oil is known as the most effective medication for loosening mucous obstructions and is useful against acute chronic respiratory conditions, such as coughs, colds, sinusitis laryngitis, and bronchitis and it also reduces acneic skin inflammation. 31) Previous investigations reported the isolation of sesquiterpenes, flavonoids, and benzoic acid derivatives 22, [32] [33] [34] [35] from D. graveolens. To the best of our knowledge, no chemical and bioactivity investigations have been carried out on D. graveolens, an endemic plant in Egypt. Moreover, this species has found no medicinal uses so far.
As part of our search for new biologically active natural products, the active epigeal parts extracts of D. graveolens were chemically investigated. The present paper describes the isolation and structural elucidation of two new eudesmane sesquiterpene derivatives, designated as 3a-hydroxyilicic acid methyl ester (1) and 2a-hydroxy-4-epi-ilicic acid (2) , together with 15 known sesquiterpenes, which were isolated and characterized from bioactive fractions of the active epigeal parts extracts of D. graveolens. In addition, our findings on the various bioactivities of crude extracts and chromatographic fractions are reported. Antibacterial and antifungal properties were assayed in vitro using laboratory microbe cultures grown on an agar medium. Antiinflammatory and antipyretic activities were assayed in vivo using laboratory rats. The potential utility in pharmaceutical developments is discussed.
tions. Individual fractions were refractionated using vacuumliquid chromatography (VLC) on a Silica gel employing gradients of CH 2 Cl 2 in hexane, EtOAc in CH 2 Cl 2 , and EtOAc. The fractions and/or subfractions were subjected to further separation and purification by size exclusion chromatography (SEC) on a Sephadex LH-20, preparative TLC, and highpressure liquid chromatography (HPLC). These procedures and bioassays of the chromatographic fractions yielded two new eudesmane sesquiterpene derivatives (1) and (2) , together with 11 known sesquiterpenes, as shown in Chart 1. Four other known sesquiterpene lactones with different carbon skeletons, named 2a-hydroxy-2R-xanthalongin (8), 4-epi-isoinuviscolide (9), 8-epi-helenalin (10), and bigelovin (11), were also isolated for the first time from the same source, as shown in Chart 2. The stereochemical structures of the isolated compounds were elucidated on the basis of physical ( 36) The only remarkable difference was the lack of the 3eq-H signal at d H 1.70-1.60 (1H, m) in (12) 36) and the appearance of a new signal at d H 4.17 (1H, t, Jϭ 2.7 Hz, H-3) attributed to a secondary hydroxyl group at C-3. The configuration at C-3 was deduced from measuring the small vicinal couplings of H-3 (J 3ax,2ax ϭJ 3ax,2eq ϭ2.7 Hz), 37, 38) indicating the presence of an C-3 axial proton and an equatorial orientation of the C-3 hydroxyl group. The 13 C-NMR spectrum of 1 (Table 1) displayed 16 carbon resonances. The two tertiary methyl groups at C-14 and C-15 were located at d C 22.5 (q) and d C 18.7 (q), respectively. Signals for carbon-bearing oxygen functions were observed at d C 167.9 (s, C-12), 76.4 (d, C-3), 75.8 (s, C-4), and 51.7 (q, C-16). An exocyclic methylene resonance was observed at d C 122.5 (t, C-13). These assignments were confirmed by 2D NMR, HSQC and HMBC spectra. The chemical shifts and multiplicities of the 13 C-singles that originated from the carbocyclic methyl ester moiety of 1 were found to be in agreement with those of vachanic acid (12) 36) except for the C-3 methylene carbon signal, which appeared at d C 43.4 (t) in vachanic acid, was replaced by an C-3 oxymethine carbon at d C 76.4 (d), indicating the presence of a secondary hydroxyl group at C-3 in compound 1. On the other hand, the 13 C-NMR spectral data of 1 were similar to those of the eudesmane derivative 3a-hydroxyilicic acid (13) 39) except that the carboxyl group -COOH, which appeared at d C 170.5 (s, C-12) in 13, was shifted upfield at d C 167.9 (s, C-12), and the appearance of a new signal at d C 51.7 (q, C-16) indicating the presence of a methyl ester group -CO 2 Me compared with the latter compound. DEPT experiments (performed at 90°a nd 135°) of 1 were also carried out to ascertain the nature of the carbon atoms, as shown in Table 1 .
Further support for the structure of 1 was obtained by acetylation using Ac 2 38, 40) further confirming the presence of a secondary hydroxyl group in the equatorial orientation at C-3 (Table 1 ). It was noteworthy that the 1 H-and 13 C-NMR spectral data of 1a
were identical to those of the methyl ester of 3a-acetylilicic acid (14) , 38) prepared by methylation of the corresponding acid.
The HMBC spectrum ( Fig. 1 ) of 1 established the placement of the hydroxyl and methyl groups at the C-3, C-4, C-14, and C-15 positions, respectively, via the correlations between H-3 and C-1, C-2, C-4, and C-14, cross-peaks between H 3 -15 and C-1, C-5, C-9, and C-10, as well as cross-peaks between H 3 -14 and C-3, C-4, and C-5. The relative stereochemistry of 1 was confirmed based on a nuclear Overhauser effect (NOE) experiment (Fig. 2) , which gave diagnostic correlations. Thus the cross-peaks between H 3 -14/H 3 -15, H-3ax, and H-6ax, as well as between H-3ax and H-2ax, established the equatorial configuration of the two hydroxyl groups at C-3 and C-4. Furthermore, the observed NOE interactions between H 3 -15, H-1ax, H-2ax, H-6ax, H-8ax, and H 3 -14 confirmed the axial orientation of the tertiary methyl group H 3 -14 and supported the equatorial orientation of the tertiary hydroxyl group at C-4. On the basis of the foregoing spectral data, compound 1 was designated as 3a-hydroxyilicic acid methyl ester with the elucidated structure methyl-3a,4a-dihydroxyeudesm-11 (13) H-2) attributed to a secondary hydroxyl group at C-2. The 13 C-NMR spectrum of 2 (Table 1) displayed 15 carbon resonances. The two tertiary methyl groups at C-14 and C-15 were located at d C 26.7 (q) and d C 18.8 (q), respectively. Resonances of carbon-bearing oxygen functions were observed at d C 172.5 (s, C-12), 70.7 (s, C-4), and 67.9 (d, C-2). An exocyclic methylene resonance was observed at d C 122.6 (t, C-13). These assignments were judged from 2D NMR, HSQC and HMBC spectra. The chemical shifts and multiplicities of the 13 C-signals originating from the carbocyclic moiety of 2 were found to be in agreement with those of D 2 -4-epi-ilicic acid (15) 42) and 3a-hydroxy-4-epi-ilicic acid (17) 44) except for the two methine carbon signals, which appeared at d C 126.2 (d, C-2) and 133.9 (d, C-3) in 15 and the oxymethine carbon signals, which appeared at d C 74.0 (d, C-3) in 17, were replaced with C-2 oxymethine carbon signals at d C 67.9 (d), confirming the presence of a secondary hydroxyl group at C-2 in compound 2. The multiplicities of the individual 13 C peaks of 2 were also determined using DEPT experiments (at 90°and 135°), as shown in Table 1 .
Further support for the structure of 2 was obtained by acetylation using Table 1) .
The HMBC experiment ( Fig. 3 ) of 2 confirmed the placement of the hydroxyl and methyl groups at the C-2, C-4, C-14, and C-15 positions, respectively, through the correlations between H-2 and C-1, C-3, C-10, and C-15, cross-peaks between H 3 -15 and C-1, C-5, C-9, and C-10, as well as crosspeaks between H 3 -14 and C-3, C-4, and C-5. The relative stereochemistry of 2 was established based on a NOESY experiment (Fig. 4) , which gave diagnostic correlations. The interactions observed between the methyl group H 3 -14 and both H-3eq, and H-5eq, established the equatorial configuration of the tertiary methyl group H 3 -14 and axial orientation of the tertiary hydroxyl group at C-4. Furthermore, the observed NOE's between H 3 -15, H-1ax, H-2ax, H-6ax, and H8ax supported the equatorial orientation of H 3 -14. The observed cross-peaks between the signals of H-2ax and H-1ax, H-3ax, and H 3 -15 confirmed the equatorial configuration of the hydroxyl group at C-2. In the light of the above spectral data, compound 2 was designated as 2a-hydroxy-4-epi-ilicic acid with the established structure 2a,4b-dihydroxyeudesm-11(13)-en-5a,7aH-12-oic acid.
2a-Hydroxy-2R-xanthalongin (8) 45) On acetylation to yield 8a (Chart 2), the proton geminal to the acetoxyl group was shifted downfield at d H 5.40 (1H, dd, Jϭ9.0, 4.0 Hz, H-2), further confirmation of the presence of a secondary hydroxyl group at C-2.
46) The 13 C-NMR spectral assignments of 8 and its acetate derivative 8a (Table 2) are not available in the literature.
The position of the OH group at C-2 was determined from the COSY correlation of H-2 (d H 4.49) with both H-3a and H-3b protons. Additional evidence was given by the HMBC long-range correlation of H-2 with C-5 (d C 121.5) and C-10 (d C 31.9), as shown by arrows in Fig. 5 . The relative stereochemical assignments of the C-2 hydroxyl group were confirmed based on a NOESY experiment (Fig. 6) , which gave diagnostic cross-peak correlations between H-2b and each of H-3b, H-3a, H-5, and H 3 -15, indicated the a-orientation of the hydroxyl group at C-2. The absolute configuration of the stereogenic center at C-2 in 8 was established using Mosher ester methodology. 47) Compound 8 was treated with (R)-(Ϫ)- and (S)-(ϩ)-a-methoxy-a-(trifluoromethyl)-phenylacetyl chloride and work-up in the usual manner to obtain the (S)-and (R)-Mosher esters. Analysis of the Dd H(S-R) data between the (S)-and (R)-esters of 8 showed a positive difference in chemical shift (ϩ0.12 ppm) for the protons at C-3. This effect indicated that the absolute configuration at C-2 is R. From the above spectral data, the structure of 8 was amended and fully characterized as 2a-hydroxy-2R-xanthalongin. Compound 8 represents a new addition to the list, as a sesquiterpene derivative has not been previously described in Inula spp. 45, 46) 4-epi-Isoinuviscolide (9) C-NMR) data with those described in the literature. 48) Other sesquiterpene acids isolated from the same plant material were fully characterized as isocostic acid (3), 32) costic acid (4), 32) 2a-hydroxyisocostic acid (5), 32) 3a-hydroxycostic acid (viscic acid) (6), 32) and ilicic acid (7). 32) In addition, six sesquiterpene lactones, namely 4,5-dioxo-11bH-xanth-1(10)-en-12,8b-oilde (18), 34) 8-epi-xanthatin-1b,5b-epoxide (19) , 33) xanthalongin (tomentosin) (20) , 32, 33) 4H-xanthalongin (21), 32) graveolide (22), 35) and 11aH,13-dihydroconfertin (23) 34) were identified by analysis of physical (mp, [a] D ) and spectroscopic evidence and confirmed by comparison of their spectral data with those published in the literature.
Antimicrobial Activity The crude plant extracts and chromatographic fractions of the epigeal parts of D. graveolens were tested using a disc diffusion assay 49) against nine species of microorganisms (four bacteria and five fungi). Bacterial species comprised two gram-positive strains, Bacillus cereus AUMC 52 and Staphylococcus aureus AUMC 54, and two gram-negative strains, Escherichia coli AUMC 53 and Serratia marcescens AUMC 55. Activities were compared against the antibiotic chloramphenicol, which was used as a positive control. Fungal test species were selected based on human pathogenic and phytopathogenic fungal species and included Aspergillus flavus AUMC 4028 (aflatoxigenic species) and Aspergillus niger AUMC 4059 (obtained from deteriorated food materials). In addition, the yeast Candida albicans AUMC 3880, Geotrichum candidum AUMC 2570 and Scopulariopsis brevicaulis AUMC 4069 (pathogenic fungi, obtained from cases of human skin diseases) were selected. Activities were compared against the antifungal agent tioconazole (Trosyd ® ), which was used as a positive control. In antibacterial testing, the crude CH 2 Cl 2 /MeOH (1 : 1) extract and chromatographic fractions C, D, E, F, and I exhibited high inhibitory activity against a gram-positive bacterium, Bacillus cereus, compared with the standard reference antibiotic chloramphenicol.
In antifungal testing, the crude CH 2 Cl 2 /MeOH (1 : 1) extract and fractions C and H displayed the same inhibitory activity as the positive control tioconazole against the human pathogenic fungi S. brevicaulis. It was also noteworthy that fractions F and G exhibited higher antifungal activity than tioconazole against the same human pathogenic fungal species. The results of the antimicrobial activity of D. graveolens extracts and chromatographic fractions are recorded in Table 3 . The observed antimicrobial activity could be attributed to the presence of sesquiterpene lactones [17] [18] [19] [20] [21] [22] and sesquiterpene acids. 23) 1540
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a) The crude extracts, chromatographic fractions and reference drugsϭ200 mg/ml. b) AUMC represents the strain number in Assiut University Mycological Center. c) 50%-100% mmϭhigh inhibition activity; 25%-Ͻ50% mmϭmedium inhibition activity; Ͻ25% mmϭlow inhibition activity; 00.0ϭno inhibition compared with the reference drugs. d) NtϭNot tested.
Antiinflammatory Activity The antiinflammatory activity of D. graveolens extracts and chromatographic fractions was tested using a reduction in yeast-induced edema bioassay. Results were compared with the reference drug indomethacin (8 mg/kg body weight), with maximum effects being obtained after 2 h.
From the obtained data, we can conclude that fractions D, E, G, and I-K exhibited more potent activity than the other fractions, exerting their maximum antiinflammatory activity after 3 h and continuing for 4 h. MeOH 80% and CH 2 Cl 2 /MeOH (1 : 1) extracts and fraction H showed similarly potent antiinflammatory activity, respectively, as the positive control indomethacin with maximum effects being observed after 4 h. Fraction F had the least potent fraction compared with the plant extracts and other tested fractions, because it exhibited low potency after 3-4 h. Fraction K was the most active fraction because it had nearly the same antiinflammatory activity as indomethacin. Therefore it can be used as an antiinflammatory agent at the dose of 300 mg/kg body weight for inhibiting the edema induced by yeast injection after carrying out other pharmacological studies on its toxicity. The results of antiinflammatory activity and inhibitory effects are shown in Table 4 . The observed antiinflammatory activity could be attributed to the presence of sesquiterpene lactones, 26, 27) sesquiterpene acids, 26, 50) triterpens and sterols, 51) and flavonoids.
50)
Antipyretic Activity The antipyretic activity of D. graveolens extracts and chromatographic fractions was tested using a reduction in yeast-induced fever bioassay. Results were compared with the reference drug indomethacin (8 mg/kg body weight), with maximum effects being obtained after 1 h.
From the observed data, we can conclude that fraction D showed a marked antipyretic activity at the dose of 300 mg/kg body weight and controlled hyperthermia after 1 h without any decrease in its activity. MeOH 80% and CH 2 Cl 2 / MeOH (1 : 1) extracts, as well as fractions K, E, J, and G showed marked antipyretic activity and controlled hyperthermia after 2 h without any decrease in activity. Fraction I showed maximum antipyretic activity after 3 h. Fraction H had less activity compared with the plant extracts and other tested fractions at the same dose level, whereas fraction F did not exhibit any antipyretic activity. Fractions D and K were very potent as antipyretic agents because they showed nearly the same antipyretic activity as the positive control indomethacin. Therefore they can be used as antipyretic agents 1542 Vol. 56, No. 11 at the dose of 300 mg/kg body weight. Data on the antipyretic activity are listed in Table 5 . The marked antipyretic activity could be attributed to the presence of sesquiterpene lactones 28) and flavonoids. 52) The in vitro antimicrobial activity as well as the in vivo antiinflammatory and antipyretic activities of the new eudesmane sesquiterpene derivatives (1) and (2) are still under investigation. To our knowledge, sesquiterpene acids have been previously reported to have only antifungal and antiinflammatory activity. 23, 26, 50) The antidermatophytic activity of these compounds is due to the presence of a free -COOH group and to the olefinic bonds in their structures.
23)

Experimental
General Experimental Procedures All melting points were measured on a Kofler hot-stage microscope and are uncorrected. UV spectra were recorded on a Shimadzu UV-160A spectrometer in MeOH. IR spectra were recorded on a Shimadzu IR-450 spectrometer.
1 H-and Extraction and Isolation The air-dried and finely powdered epigeal parts of D. graveolens (1.5 kg) were exhaustively extracted successively with CH 2 Cl 2 /MeOH (1 : 1, v/v), followed by 80% MeOH at ambient temperature, which furnished 35 and 22 g, respectively.
The crude CH 2 Cl 2 /MeOH (1 : 1) extract (35 g) was subjected to column chromatography on a Silica gel (1050 g, 4ϫ120 cm) to give 11 fractions: fraction A (hexane, 11), fraction B (Et 2 O/hexane 1 : 9, 11), fraction C (Et 2 O/ hexane 1 : 3, 11), fraction D (Et 2 O/hexane 1 : 1, 11), fraction E (Et 2 O/hexane 3 : 1, 11), fraction F (Et 2 O, 11), fraction G (Me 2 CO/Et 2 O 1.5 : 8.5, 11), fraction H (Me 2 CO/Et 2 O 1 : 3, 11), fraction I (Me 2 CO/Et 2 O 1 : 1, 11), fraction J (Me 2 CO, 11), and fraction K (MeOH, 11). Bioassay-guided analyses of the crude CH 2 Cl 2 /MeOH (1 : 1), MeOH 80% extracts, and chromatographic fractions were performed (vide infra).
Fractions A and B corresponding to elution in the range hexane-10% Et 2 O in hexane were similar in TLC and NMR, and were thus combined. Fractions A and B (ca. 2.0 g overall) contained mainly waxes and volatile terpenes and were discarded. Fraction G corresponding to elution with 15% Me 2 CO in Et 2 O (ca. 2.0 g) was purified in preparatory HPLC using an RP-18 column with MeOH/H 2 O (3 : 1, v/v) to afford 1 (12 mg, 0.0008% on dry plant material, t R 3.5 min) and 2 (10 mg, 0.0007%, t R 5.5 min). Fraction D (ca. 6.5 g) was subjected to gelfiltration on a Sephadex LH-20 eluted with C 6 H 14 /CH 2 Cl 2 /MeOH (7 : 4 : 1) and the resulting subfractions were further purified in preparatory HPLC using an RP-18 column with MeOH/H 2 O (4 : 1, v/v) and a flow rate of 1.5 ml/min to afford 3 (8 mg, 0.0005%), 4 (15 mg, 0.001%), 5 (3 mg, 0.0002%), 6 (3.5 mg, 0.0002%), 7 (5000 mg, 0.33%) , and 23 (40 mg, 0.003%). Fraction E (ca. 8.3 g) was absorbed on 5.0 g of a Silica gel and placed onto a VLC column (2.5 cm in diameter and 30 cm long) packed with 120 g of a Silica gel. Fraction E was separated into nine subfractions (EA-EI, 100 ml each), using gradients of CH 2 Cl 2 in hexane and EtOAc in CH 2 Cl 2 , followed by EtOAc. The subfractions EE-EI were further purified by gelfiltration on a Sephadex LH-20 eluted with C 6 H 14 / CH 2 Cl 2 /MeOH (7 : 4 : 1) and preparatory HPLC using an RP-18 column with MeOH/H 2 O (8.5 : 1.5, v/v) and a flow rate of 1.5 ml/min to afford 5 (7 mg, 0.0005%), 6 (5 mg, 0.0003%), 8 (11 mg, 0.0007%), 9 (8.5 mg, 0.0006%), 10 (7 mg, 0.0005%), and 11 (6.2 mg, 0.0004%). The other subfractions EA-ED were further purified by PTLC: hexane/Et 2 O (1 : 1, 1 : 2, 1 : 4) and benzene/CH 2 Cl 2 (1 : 1, with different amounts of Et 2 O, several developments) to yield 18 (9 mg, 0.0006%), 19 (100 mg, 0.007%), 20 (19.5 mg, 0.001%), and 21 (18 mg, 0.001%). Fraction C (ca. 2.5 g) was subjected to gelfiltration on a Sephadex LH-20 eluted with C 6 H 14 /CH 2 Cl 2 /MeOH (7 : 4 : 0.5) and further purified by PTLC: hexane/Et 2 O (4 : 1, 1 : 1, two developments) and preparatory HPLC using an RP-18 column with MeOH/H 2 O (9 : 1, v/v) and a flow rate of 1.5 ml/min to afford 22 (500 mg, 0.033%), 23 (10 mg, 0.0007%), 4 (5 mg, 0.0003%), and 7 (100 mg, 0.007%).
3a-Hydroxyilicic Acid Methyl Ester; Methyl-3a,4a-dihydroxyeudesm-11(13)-en-5a,7aH-12-oate (1) Table 1. 3a-Acetoxyilicic Acid Methyl Ester (1a): Compound 1 (6.5 mg) was acetylated with Ac 2 O/pyridine (1 : 1, 5 ml) at room temperature for 24 h and worked up in the usual manner to yield the corresponding monoacetate 1a (3.7 mg Table 2 .
4-epi-Isoinuviscolide (9) 48) Antimicrobial Assays Evaluation of the antimicrobial activity was carried out in the Mycological Center, Assuit University, Assuit, Egypt, according to the disc diffusion assay protocol 49) with some modifications. Bacterial strain inocula were prepared as cell suspensions at a concentration of approximately 10 5 CFU/ml for 24 h cultures grown in nutrient broth at 37Ϯ 1°C. Yeasts and filamentous fungal inocula were prepared as cell or spore suspensions at a concentration of approximately 10 4 CFU/ml for 48 h yeast cultures or 7-d mold cultures grown at 28Ϯ1°C on Sabouraud's dextrose broth. Every inoculum was spread on a plate containing nutrient agar in the case of bacteria or Sabouraud's agar in the case of fungi. The crude plant extracts and chromatographic fractions, as well as the reference drugs chloramphenicol (Misr Co. for Pharm. Ind.) and tioconazole (Trosyd ® , Pfizer Egypt) used as positive controls were dissolved in dimethyl sulphoxide (DMSO) to prepare 200 mg/ml solutions. The filter paper discs (5 mm diameter, Whatman 3 mm) were impregnated with 10 ml of the above-mentioned solutions. At the time of inoculation, discs were placed on the surface of agar medium in Petri dishes (3 discs per plate) under aseptic conditions. The cultures were incubated at 37Ϯ1°C for 48 h for the antibacterial assay and at 28Ϯ1°C for 3-7 d for the antifungal assay. The diameters of the inhibition zones around the discs were measured in millimeters to evaluate the antimicrobial activity.
The antimicrobial activity of the CH 2 Cl 2 /MeOH (1 : 1) and MeOH 80% extracts, and chromatographic fractions A-K of the epigeal parts of D. graveolens as well as the reference drugs chloramphenicol and tioconazole are shown in Table 3 . Every experiment in the antibacterial and antifungal assays was performed in duplicate.
Pharmacological Studies. Animals Male albino rats (100-120 g) were housed under standardized environmental conditions of temperature and humidity at the Pre-Clinical Animal House, Pharmacology Department, Faculty of Medicine, Assiut University, Assiut, Egypt. They were fed a standard diet ad libitum and allowed free access to drinking water in rooms with a controlled 12/12 h light/dark cycle (08:00 a.m. to 20:00 p.m.). All animals were acclimatized for at least 1 week before the experiments.
Preparation of Test Drugs Indomethacin, brewer's yeast, and polysorbate 80 USP (Tween 80) were purchased from Sigma Chemical Co. All test drugs including the crude plant extracts and chromatographic fractions were dissolved or suspended in 2% polysorbate 80 (Tween 80) in normal saline, which was used as a vehicle. Test drugs were administered intraperitoneally (i.p.) with a volume equivalent to 1 ml/100 g body weight of the animals.
Control group animals were injected only with 2% Tween 80 in normal saline (vehicle) in the same volume.
Antiinflammatory Activity Antiinflammatory activity was measured according to the method described by Winter C. A. et al. 53) Sixty male rats weighing 100-120 g were divided into 12 groups of 5 animals each. The right paw, or control paw, was injected with 2% Tween alone in normal saline (vehicle). Edema was induced on the left hind paw by subplantar injection of 20% brewer's yeast suspension in vehicle at a dose of 1 ml/100 g body weight. Indomethacin 8 mg/kg body weight was injected i.p. 30 min before examining paw swelling. The CH 2 Cl 2 /MeOH (1 : 1) and MeOH 80% extracts, as well as chromatographic fractions D-K of the epigeal parts of D. graveolens were injected at a dose 300 mg/kg of body weight i.p. 1 h after induction of inflammation. Paw thickness was measured 30, 60, 120, 180, and 240 min after. The percentage of edema and percentage of inhibition were calculated as follows: % edemaϭ(right paw thicknessϪleft paw thickness) ϫ100/right paw thickness % inhibitionϭV 0 ϪV 1 ϫ100/V 0 where V 0 is the average paw thickness in the control group and V 1 is the average paw thickness in the treated group. The antiinflammatory and inhibitory effects of the crude plant extracts and chromatographic fractions as well as the reference drug are shown in Table 4 . Antipyretic Activity The initial rectal temperature of the rats was recorded using an electric thermometer, and animals with a temperature 37°C were selected for the test. Hyperthermia was induced in the rats by injection of 20% brewer's yeast suspension in vehicle in a dose of 1 ml/100 g body weight subcutaneously (s.c.). 52, 54) Then the animals were fasted but allowed access to water until the termination of the experiments performed in a temperature-controlled room. Only rats that developed satisfactory pyrexia (1.0°C or greater increase in rectal temperature) were used. When temperature was at a peak (20 h after yeast injection), the rectal temperature was again recorded. The rats were randomly divided into 12 groups of 5 animals each. Then the crude plant extracts and chromatographic fractions D-K of D. graveolens (300 mg/kg each), indomethacin (8 mg/kg), and control vehicle were administered s.c. The rectal temperature was recorded at 30-min intervals for 4 h following the administration of test drugs. The results of the antipyretic activity of the crude plant extracts and chromatographic fractions as well as the reference drug are listed in Table 5 .
Statistical Analysis Data are expressed as meanϮS.E. or as percentages (Tables 4, 5 ). Differences between the control and the treatment groups were tested for statistical significance using Student's t-test. p values of less than 0.05 were considered to be statistically significant.
